Paper Gains From Research Monkey Valuations Lift Joinn's Profitbenzinga_article·Jul 23 at 09:08 AM06127+0.86%603127-0.10%
Xbrane Biopharma Q2 FY26 net loss widens to SEK 11.4 million; revenue rises to SEK 46.8 millionPUBT·Jul 17 at 01:31 AM603127-0.10%06127+0.86%
STOCKS | Zhaoyan New Drug Warns of Overheated Sentiment and Irrational Speculation RiskCoinLive·Jul 16 at 03:57 AM603127-0.10%06127+0.86%
JOINN Surges Over 7%; Interim Profit Expected to Jump Up to 13.77x to RMB900 MillionAASTOCKS News·Jul 14 at 08:55 PM603127-0.10%06127+0.86%
JOINN Laboratories Flags Surging Interim Profit on Biological Asset GainsTip Ranks·Jul 14 at 07:38 AM06127+0.86%603127-0.10%
Xbrane and JOINN Forge Partnership to Advance Darzalex Biosimilar XdarzaneTip Ranks·Jun 11 at 01:32 PM06127+0.86%603127-0.10%
